NBTX is Nanobiotix S.A. (Healthcare) — a non-dividend-paying stock. Trading at $40.00. Market cap: $2.12B.
Stock snapshot
| Price | $40.00 |
| Market cap | $2.12B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About NBTX
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Related non-dividend companies
Other non-dividend stocks investors research alongside NBTX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is NBTX's current stock price?
NBTX (Nanobiotix S.A.) is currently trading at $40.00.
Does NBTX pay a dividend?
NBTX (Nanobiotix S.A.) does not currently pay a regular dividend.
Track NBTX in DiviDrip
Add NBTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search NBTX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.